Adient (NYSE:ADNT) Price Target Raised to $40.00

Adient (NYSE:ADNTGet Rating) had its target price lifted by research analysts at Deutsche Bank Aktiengesellschaft to $40.00 in a research note issued on Thursday, The Fly reports. Deutsche Bank Aktiengesellschaft’s price target would suggest a potential downside of 5.19% from the stock’s current price.

Several other research firms also recently weighed in on ADNT. Morgan Stanley increased their target price on Adient from $27.00 to $29.00 and gave the stock an “underweight” rating in a research report on Monday, November 28th. Bank of America upgraded Adient from a “neutral” rating to a “buy” rating and upped their price target for the stock from $41.00 to $52.00 in a research note on Monday, January 9th. StockNews.com upgraded Adient from a “hold” rating to a “buy” rating in a research note on Wednesday, January 11th. Wells Fargo & Company increased their target price on Adient from $37.00 to $42.00 and gave the company an “overweight” rating in a research note on Monday, November 7th. Finally, Royal Bank of Canada lowered Adient from an “outperform” rating to a “sector perform” rating and set a $36.00 target price for the company. in a research note on Monday, November 7th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, Adient has a consensus rating of “Hold” and a consensus target price of $39.75.

Adient Stock Performance

NYSE ADNT opened at $42.19 on Thursday. The business’s 50-day moving average price is $37.54 and its 200 day moving average price is $34.40. Adient has a twelve month low of $27.15 and a twelve month high of $50.22. The company has a market capitalization of $4.00 billion, a PE ratio of -33.22 and a beta of 2.62. The company has a current ratio of 1.19, a quick ratio of 0.92 and a debt-to-equity ratio of 1.08.

Adient (NYSE:ADNTGet Rating) last released its earnings results on Friday, November 4th. The company reported $0.53 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.02. Adient had a positive return on equity of 0.43% and a negative net margin of 0.85%. The firm had revenue of $3.65 billion for the quarter, compared to the consensus estimate of $3.55 billion. On average, research analysts predict that Adient will post 2.45 earnings per share for the current year.

Insider Buying and Selling at Adient

In other Adient news, EVP Michel Pierre Rose Berthelin sold 1,200 shares of the firm’s stock in a transaction that occurred on Wednesday, November 9th. The stock was sold at an average price of $36.62, for a total transaction of $43,944.00. Following the completion of the sale, the executive vice president now owns 44,453 shares in the company, valued at approximately $1,627,868.86. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Adient news, EVP Jerome J. Dorlack sold 4,300 shares of the stock in a transaction that occurred on Wednesday, November 23rd. The stock was sold at an average price of $39.09, for a total transaction of $168,087.00. Following the transaction, the executive vice president now owns 139,396 shares of the company’s stock, valued at approximately $5,448,989.64. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Michel Pierre Rose Berthelin sold 1,200 shares of the stock in a transaction that occurred on Wednesday, November 9th. The stock was sold at an average price of $36.62, for a total value of $43,944.00. Following the transaction, the executive vice president now directly owns 44,453 shares in the company, valued at approximately $1,627,868.86. The disclosure for this sale can be found here. Insiders sold a total of 86,762 shares of company stock worth $3,411,963 in the last 90 days. 0.68% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. FourThought Financial LLC lifted its holdings in shares of Adient by 19.0% in the 3rd quarter. FourThought Financial LLC now owns 1,838 shares of the company’s stock worth $51,000 after purchasing an additional 293 shares during the last quarter. First Republic Investment Management Inc. lifted its holdings in shares of Adient by 1.0% in the 3rd quarter. First Republic Investment Management Inc. now owns 32,482 shares of the company’s stock worth $901,000 after purchasing an additional 317 shares during the last quarter. Greenwich Wealth Management LLC lifted its holdings in shares of Adient by 2.8% in the 2nd quarter. Greenwich Wealth Management LLC now owns 18,279 shares of the company’s stock worth $542,000 after purchasing an additional 500 shares during the last quarter. US Bancorp DE lifted its holdings in shares of Adient by 16.7% in the 3rd quarter. US Bancorp DE now owns 4,225 shares of the company’s stock worth $117,000 after purchasing an additional 604 shares during the last quarter. Finally, Xponance Inc. lifted its holdings in shares of Adient by 5.6% in the 2nd quarter. Xponance Inc. now owns 14,662 shares of the company’s stock worth $434,000 after purchasing an additional 773 shares during the last quarter. Institutional investors own 93.20% of the company’s stock.

Adient Company Profile

(Get Rating)

Adient plc, an investment holding company, engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.

Featured Stories

The Fly logo

Analyst Recommendations for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.